Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Serplulimab Injection

Approval Number

国药准字S20220013

Company上海复宏汉霖生物制药有限公司

Registration Date

March 22, 2022

Drug Information

Generic Name

斯鲁利单抗注射液

Trade Name

汉斯状

Dosage Form

注射剂

Strength

100mg（10ml）/瓶

Drug Type

生物制品

Registration Date

March 22, 2022

Company Information

Applicant Company

Company Name上海复宏汉霖生物制药有限公司

Company Address

上海市徐汇区宜山路1289号1幢（D楼）全幢

Manufacturing Company

Company Name上海复宏汉霖生物制药有限公司

Company Address

上海市徐汇区宜山路1289号1幢（D楼）全幢

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

斯鲁利单抗注射液 - NMPA 批准文号 | MedPath